Managing moderate and severe asthma: Ignite Webinar

Tuesday 26th May 2020
7:00pm – 8:00pm (AEST)

Professor Norbert Berend, Global Medical Expert, GSK

This webinar will discuss treatment options including recent developments for patients with moderate and severe asthma. The role of anti-IL5 monoclonal antibodies for the treatment of severe eosinophilic asthma will also be reviewed.

Learning Objectives:

1. Understand differences in the real world effectiveness of ICS/LABA medications
2. Discuss the burden of severe asthma including the impact of exacerbations and OCS use
3. Discuss the role of primary care physicians in supporting the identification and post treatment management of severe asthma patients
   
4. Introduction to Nucala(mepolizumab) including, efficacy, long term safety and the introduction of a new formulation for self-administration

Find out more and register here.